NCT00597675View on ClinicalTrials.gov

Oral Immunotherapy for Peanut Allergy (PMIT)

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Food Hypersensitivity
Interventions
BIOLOGICAL

Peanut OIT

Defatted peanut flour ingested daily as oral mucosal immunotherapy

BIOLOGICAL

Placebo

Oat flour matched by weight and consistency that is ingested daily as a placebo

Trial Locations (2)

27599

University of North Carolina, Chapel Hill

72202

University of Arkansas Medical Center, Little Rock

All Listed Sponsors
collaborator

University of Arkansas

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT00597675 - Oral Immunotherapy for Peanut Allergy (PMIT) | Biotech Hunter | Biotech Hunter